Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LRRK2 | Q5S007 | 3/20 | 0.47 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.39 |
| ▸ | GAK | O14976 | 4/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | BACE1 | P56817 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.34 |
| ▸ | SYK | P43405 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2214872 | 0.81 | TDP1 (0.40) | LRRK2GAKKDM4EMEN1ALDH1A1 | |
| SCHEMBL2214511 | 0.80 | GAK (0.36) | GAKKDM4EMEN1ALDH1A1KMT2A | |
| SCHEMBL2214156 | 0.80 | GAK (0.38) | LRRK2GAKKDM4EMEN1ALDH1A1 | |
| SCHEMBL2216542 | 0.80 | LRRK2 (0.43) | LRRK2FFAR4GAKKDM4EMEN1 | |
| SCHEMBL2212997 | 0.78 | GAK (0.35) | LRRK2GAKKDM4EMEN1ALDH1A1 | |
| SCHEMBL2215363 | 0.78 | LRRK2 (0.40) | LRRK2GAKKDM4EMEN1ALDH1A1 | |
| SCHEMBL2214218 | 0.77 | LRRK2 (0.44) | LRRK2GAKKDM4EMEN1ALDH1A1 | |
| SCHEMBL2214626 | 0.77 | CYP2C9 (0.36) | LRRK2GAKKDM4EMEN1ALDH1A1 | |
| SCHEMBL3809787 | 0.77 | CYP2C9 (0.36) | LRRK2GAKKDM4EMEN1ALDH1A1 | |
| SCHEMBL2216042 | 0.77 | GAK (0.41) | LRRK2GAKKDM4EMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110178064-A1 | SPIRO CONDENSED BARBITURIC ACID DERIVATIVES FOR USE AS ANTIBACTERIAL | ASTRAZENECA R&D (SE) | 2011-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110178064-A1 | SPIRO CONDENSED BARBITURIC ACID DERIVATIVES FOR USE AS ANTIBACTERIAL | TBCA, TUBA1A, BROX | LRRK2 414/4885FFAR4 2924/4885GAK 1986/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.